Smedo is focused on revolutionizing vital sign measurement by providing contactless, cost-effective, precise, and versatile solutions adaptable to a wide range of environments and applications. The Germany-based startup's innovative sensor detects micro-vibrations of the skin to accurately determine vital signs such as heart rate, HRV, heartbeat sounds, respiration rate, and blood pressure. The company's last funding round, a €1.66M Seed Round investment, was secured on 26 April 2022 from BC Brandenburg Capital and Apex Ventures Inc. Smedo's advanced monitoring system tracks biometrics in defined areas, with the ability to trigger acoustic or digital alarms and produce insightful reports whenever necessary. With a range of up to 7 meters even through clothing, in motion, and in low light conditions, Smedo ensures maximum freedom and comfort for both personnel and patients while delivering uninterrupted, reliable vital data. Smedo aims to sense vital signs without wires, restrictions, or any added effort, operating within the Health Care, IoT, and Medical Devices industries.
No recent news or press coverage available for smedo.